Latest Period
Q2 2026
Security Snapshot
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) Institutional Ownership
CUSIP: 03168L105
13F Institutional Holders and Ownership History from Q2 2018 to Q2 2026
Institutions Reporting
302
Shares (Excl. Options)
162,024,909
Price
$17.31
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Common Stock, par value $0.01
- Symbol
- AMRX on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 162,024,909
- Total 13F value
- $2,801,526,518
- Portfolio coverage rank
- 0%
- Share change
- +2,488,080
- Value change
- +$58,478,901
- Number of holders
- 302
- Shares outstanding
- 348,532,261
- SEC-reported price per share
- $17.50
- Insider filing price
- $17.50
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 is tracked under CUSIP 03168L105.
- 302 institutions reported positions in Q2 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 315 to 302 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,987,154,581 to $2,801,526,518.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 302 institutions filings for Q2 2026.
Security key
03168L105
Latest holder period
Q2 2026
13F holders
302
13D/G owners
6
CIK / CUSIP context first
Open Q2 2026 holders
AMRX full holder history
Amneal Pharmaceuticals, Inc. SEC filings
Amneal Pharmaceuticals, Inc. company facts
Amneal Pharmaceuticals, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03168L105:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
AMRX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Patel Tushar Bhikhubhai | 18% | +12% | $1,061,824,446 | +$220,935,648 | 61,341,678 | +26% | Tushar Patel | 10 Aug 2026 |
| Patel Chintu | 9.4% | +15% | $563,899,700 | +$115,397,046 | 32,576,528 | +26% | Chintu Patel | 10 Aug 2026 |
| Patel Chirag K. | 8.4% | +19% | $503,680,235 | +$119,737,147 | 29,097,645 | +31% | Chirag Patel | 10 Aug 2026 |
| Mahesh Akram | 6.6% | $153,779,517 | 20,558,759 | Akram Mahesh | 31 Mar 2025 | |||
| Patel Dipan | 5.4% | -28% | $244,942,771 | -$100,339,323 | 16,904,263 | -29% | Patel Dipan | 31 Dec 2025 |
| VANGUARD GROUP INC | 5% | $117,905,198 | 15,762,727 | The Vanguard Group | 31 Mar 2025 |
As of 30 Jun 2026, 302 institutional investors reported holding 162,024,909 shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX). This represents 46% of the company’s total 348,532,261 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
36%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7.6% | 26,562,093 | +8.3% | 0.01% | $459,789,829 |
| TPG GP A, LLC | 3.5% | 12,328,767 | 0% | 4.3% | $213,410,957 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.5% | 12,137,727 | +7.2% | 0.01% | $210,104,054 |
| Rubric Capital Management LP | 2.9% | 10,168,660 | -7.9% | 1.6% | $176,019,505 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.2% | 7,710,126 | +1.6% | 0% | $133,462,281 |
| STATE STREET CORP | 2.1% | 7,356,977 | +8.3% | 0% | $127,349,272 |
| DIMENSIONAL FUND ADVISORS LP | 1.7% | 5,794,263 | +1.8% | 0.02% | $100,298,335 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.5% | 5,139,449 | +13% | 0% | $88,977,436 |
| MORGAN STANLEY | 1.2% | 4,110,028 | -11% | 0% | $71,144,597 |
| NEUBERGER BERMAN GROUP LLC | 1.1% | 3,887,179 | +5.6% | 0.04% | $67,280,885 |
| Invesco Ltd. | 1% | 3,502,000 | +9.8% | 0% | $60,619,620 |
| Nuveen, LLC | 0.95% | 3,324,875 | +2.5% | 0.01% | $57,553,586 |
| Allspring Global Investments Holdings, LLC | 0.95% | 3,295,533 | +29% | 0.09% | $55,925,195 |
| GOLDMAN SACHS GROUP INC | 0.86% | 3,013,961 | +5.2% | 0.01% | $52,171,665 |
| Assenagon Asset Management S.A. | 0.7% | 2,445,549 | -20% | 0.05% | $42,332,453 |
| Nantahala Capital Management, LLC | 0.65% | 2,268,751 | -20% | 2.4% | $39,272,080 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.62% | 2,147,450 | -1.7% | 0% | $37,172,360 |
| NORTHERN TRUST CORP | 0.55% | 1,914,895 | +12% | 0% | $33,146,832 |
| ACADIAN ASSET MANAGEMENT LLC | 0.47% | 1,650,255 | -15% | 0.03% | $28,555,000 |
| AMERIPRISE FINANCIAL INC | 0.45% | 1,581,869 | -15% | 0.01% | $27,386,895 |
| Westshore Wealth, LLC | 0.39% | 1,366,274 | -0.56% | 7.3% | $23,650,203 |
| BlackBarn Capital Partners LP | 0.37% | 1,300,000 | -21% | 5.6% | $22,503,000 |
| Penn Capital Management Company, LLC | 0.34% | 1,181,176 | -1.2% | 1.3% | $20,483,557 |
| VANGUARD FIDUCIARY TRUST CO | 0.34% | 1,169,282 | +1.3% | 0% | $20,240,271 |
| CITADEL ADVISORS LLC | 0.32% | 1,118,715 | +94% | 0.01% | $19,364,957 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
33
Latest
Q2 2026
Rows shown
1-25 of 33
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 162,024,909 | $2,801,526,518 | +$58,478,901 | $17.31 | 302 |
| 2026 Q1 | 159,884,372 | $1,987,154,581 | +$46,873,345 | $12.43 | 315 |
| 2025 Q4 | 154,615,634 | $1,947,916,977 | +$47,523,787 | $12.60 | 278 |
| 2025 Q3 | 150,638,837 | $1,508,259,054 | +$80,688,644 | $10.01 | 243 |
| 2025 Q2 | 141,656,835 | $1,146,033,099 | +$54,531,142 | $8.09 | 237 |
| 2025 Q1 | 134,631,456 | $1,128,246,067 | +$84,513,755 | $8.38 | 232 |
| 2024 Q4 | 125,924,024 | $997,296,789 | -$136,424,861 | $7.92 | 194 |
| 2024 Q3 | 142,604,811 | $1,186,537,394 | +$32,304,784 | $8.32 | 180 |
| 2024 Q2 | 138,637,695 | $880,361,225 | +$192,128,358 | $6.35 | 179 |
| 2024 Q1 | 108,100,411 | $655,086,509 | -$6,545,489 | $6.06 | 173 |
| 2023 Q4 | 109,241,884 | $663,112,026 | +$52,701,039 | $6.07 | 151 |
| 2023 Q3 | 101,896,343 | $430,042,448 | +$19,693,333 | $4.22 | 141 |
| 2023 Q2 | 97,368,877 | $301,754,419 | +$4,221,215 | $3.10 | 122 |
| 2023 Q1 | 96,883,833 | $134,657,443 | -$8,205,387 | $1.39 | 142 |
| 2022 Q4 | 101,876,885 | $202,739,453 | +$4,463,674 | $1.99 | 155 |
| 2022 Q3 | 99,522,767 | $201,053,119 | -$1,681,376 | $2.02 | 144 |
| 2022 Q2 | 99,362,374 | $315,991,849 | -$2,095,558 | $3.18 | 140 |
| 2022 Q1 | 100,125,536 | $417,146,539 | -$2,779,055 | $4.17 | 154 |
| 2021 Q4 | 100,743,592 | $481,044,810 | -$750,941 | $4.79 | 148 |
| 2021 Q3 | 100,372,906 | $535,260,080 | +$2,515,423 | $5.34 | 150 |
| 2021 Q2 | 99,933,342 | $511,565,477 | -$13,076,955 | $5.12 | 153 |
| 2021 Q1 | 101,580,612 | $683,525,934 | +$24,752,974 | $6.73 | 155 |
| 2020 Q4 | 99,489,363 | $454,601,386 | -$9,010,325 | $4.57 | 128 |
| 2020 Q3 | 101,459,246 | $393,634,017 | -$1,370,007 | $3.88 | 133 |
| 2020 Q2 | 101,691,059 | $484,034,077 | +$16,566,905 | $4.76 | 131 |